Study of SAR441566 for Ulcerative Colitis
Part of Digestive system clinical trials.
This trial tests a new medicine called SAR441566 for people with moderate-to-severe ulcerative colitis (UC). It may help reduce symptoms like bleeding and diarrhea if other treatments haven't worked well enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had active UC for at least 3 months, confirmed by a colonoscopy.
- Your UC is moderate to severe, with frequent bleeding and diarrhea.
- You have tried standard treatments (like 5-ASA or steroids) or advanced treatments (like biologics or JAK inhibitors) and they didn't work well or you couldn't tolerate them.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
- You do not have other types of colitis, active infections (like TB, hepatitis, or HIV), or a history of certain cancers or bowel surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
This study tests several new treatments to see if they are safe and helpful for people with moderate to severe ulcerative colitis. If you have not responded well to standard treatments, this might be an option.
This trial tests an investigational drug called MK-8690 for people with moderate to severe ulcerative colitis (UC) who haven't responded well to other treatments or can't tolerate them. The study aims to see if the drug can help control UC symptoms safely.
This study tests an experimental drug called SAR442970 for people with moderate to severe Crohn's disease who haven't had success with standard treatments or biologics. The goal is to see if it can reduce inflammation and improve symptoms.
This study tests an investigational medication called LY4268989 for adults with moderate to severe ulcerative colitis (UC). It's for people who have tried other treatments without success. The goal is to see if the drug can reduce inflammation and improve symptoms.
This study tests a new drug called XmAb942 for people with moderate to severe ulcerative colitis. It aims to see if the drug can reduce inflammation and improve symptoms when other treatments haven't worked well enough or caused side effects.
Hear when a new Colitis Ulcerative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.